SSP Aims for 10% Market Share with Switch OTC Alesion 10

October 19, 2011
SSP held a press event on October 19 to announce the upcoming launch of the allergic rhinitis treatment Alesion 10, Japan’s first switch OTC product containing the ethical drug epinastine HCl. The company announced that it aims to gain a...read more